Robert. W. Wong, MD | Best Retina ...

Dr. Robert Wong, MD

Claim this profile

Austin Retina Associates

Studies Diabetic Retinopathy
Studies Age-Related Macular Degeneration
6 reported clinical trials
11 drugs studied

Affiliated Hospitals

Image of trial facility.
Austin Retina Associates
Image of trial facility.
VA Palo Alto Healthcare System

Clinical Trials Robert Wong, MD is currently running

Image of trial facility.

4D-150

for Age-Related Macular Degeneration

Phase 1/2 dose-escalation and randomized, controlled, masked expansion trial in adults with wet AMD undergoing active anti-VEGF treatment. Substudies will evaluate the safety and tolerability of 4D-150 contralateral eye dosing and characterize vector shedding.
Recruiting1 award Phase 1 & 23 criteria
Image of trial facility.

Fenofibrate

for Diabetic Retinopathy

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the feasibility of a model for ophthalmologists to prescribe or collaborate with a primary care provider such as an internist/endocrinologist to prescribe and monitor the drug safely. If this study demonstrates that fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community of retina specialists, a new strategy to prevent vision threatening complications of diabetes could be widely adopted. Widespread use of an oral agent effective at reducing worsening of DR would decrease the numbers of patients who undergo more invasive and much more expensive treatment for DR and who are consequently at risk for side effects that adversely affect visual function. This study will also assess the relationship of glycemic variability, as measured by continuous glucose monitoring with DR outcomes. Ancillary studies will characterize functional and structural outcomes in this cohort.
Recruiting1 award Phase 35 criteria

More about Robert Wong, MD

Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Robert Wong, MD has experience with
  • Fenofibrate
  • Placebo
  • Oncoguard™ Liver Test
  • Standard Of Care CT/MRI Imaging
  • Study CT/MRI Imaging
  • Faricimab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Robert Wong, MD specialize in?
Is Robert Wong, MD currently recruiting for clinical trials?
Are there any treatments that Robert Wong, MD has studied deeply?
What is the best way to schedule an appointment with Robert Wong, MD?
What is the office address of Robert Wong, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security